FLH Co-Sponsors and FLH Partners Charles Raubicheck and Brian Malkin Speak at ACI's Follow-On Biologics Conference
On June 21-22, Frommer Lawrence & Haug will co-sponsor the first major biosimilar / follow-on biologics event hosted by the American Conference Institute in New York. Partners Charles J. Raubicheck and Brian J. Malkin will speak on key regulatory topics for obtaining approval of biosimilars, including demonstrating "interchangeability" with the reference biological and developing alternative pathways for approval. Policy makers, in-house representatives from life sciences branded, generic, and biotech companies and representatives from key government agencies and industry association will provide an in-depth analysis of the legal, regulatory, policy, and business issues surrounding follow-on biologics. For more information, click here.